New diabetes clinical trial: A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Published on: April 16, 2019 at 07:00PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: ADO09 formulation;   Drug: Placebo;   Drug: Symlin®;   Drug: Humulin®;   Drug: Humalog®
Sponsor:   Adocia
Completed